Global Hydronephrosis Therapies Market 2019-2023: Market to Grow at a CAGR of 9.14%

Dublin, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The "Global Hydronephrosis Therapies Market 2019-2023" report ...

Global Hydronephrosis Therapies Market 2019-2023: Market to Grow at a CAGR of 9.14%

Dublin, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The "Global Hydronephrosis Therapies Market 2019-2023" report ...

Ballad Health reports first quarter results

Strong financial results, significant capital investment highlight first quarter with combined budget JOHNSON CITY, ...

FibroGen Reports Third Quarter 2018 Financial Results

—Roxadustat New Drug Applications under Review in China and Japan——Phase 3 Clinical Trials in ...

Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

AUSTIN, Texas, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage ...

XBiotech berichtet über Entwicklungen im dritten Quartal 2018

Unternehmen stellt aktualisierte Übersicht zur klinischen und Entdeckungs-Pipeline sowie anderen Unternehmensinitiativen vor AUSTIN, Texas, ...

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 ...

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 ...

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 ...

XBiotech Highlights Third Quarter Developments for 2018

Company Provides Updated Overview including on its Clinical and Discovery Pipeline as well as ...